118 related articles for article (PubMed ID: 3806204)
1. Brain-stem tumors in childhood: a prospective randomized trial of irradiation with and without adjuvant CCNU, VCR, and prednisone. A report of the Childrens Cancer Study Group.
Jenkin RD; Boesel C; Ertel I; Evans A; Hittle R; Ortega J; Sposto R; Wara W; Wilson C; Anderson J
J Neurosurg; 1987 Feb; 66(2):227-33. PubMed ID: 3806204
[TBL] [Abstract][Full Text] [Related]
2. The treatment of medulloblastoma. Results of a prospective randomized trial of radiation therapy with and without CCNU, vincristine, and prednisone.
Evans AE; Jenkin RD; Sposto R; Ortega JA; Wilson CB; Wara W; Ertel IJ; Kramer S; Chang CH; Leikin SL
J Neurosurg; 1990 Apr; 72(4):572-82. PubMed ID: 2319316
[TBL] [Abstract][Full Text] [Related]
3. Randomized phase III trial in childhood high-grade astrocytoma comparing vincristine, lomustine, and prednisone with the eight-drugs-in-1-day regimen. Childrens Cancer Group.
Finlay JL; Boyett JM; Yates AJ; Wisoff JH; Milstein JM; Geyer JR; Bertolone SJ; McGuire P; Cherlow JM; Tefft M
J Clin Oncol; 1995 Jan; 13(1):112-23. PubMed ID: 7799011
[TBL] [Abstract][Full Text] [Related]
4. Adjuvant chemotherapy of childhood posterior fossa ependymoma: cranio-spinal irradiation with or without adjuvant CCNU, vincristine, and prednisone: a Childrens Cancer Group study.
Evans AE; Anderson JR; Lefkowitz-Boudreaux IB; Finlay JL
Med Pediatr Oncol; 1996 Jul; 27(1):8-14. PubMed ID: 8614396
[TBL] [Abstract][Full Text] [Related]
5. The effectiveness of chemotherapy for treatment of high grade astrocytoma in children: results of a randomized trial. A report from the Childrens Cancer Study Group.
Sposto R; Ertel IJ; Jenkin RD; Boesel CP; Venes JL; Ortega JA; Evans AE; Wara W; Hammond D
J Neurooncol; 1989 Jul; 7(2):165-77. PubMed ID: 2550594
[TBL] [Abstract][Full Text] [Related]
6. Outcome for children with medulloblastoma treated with radiation and cisplatin, CCNU, and vincristine chemotherapy.
Packer RJ; Sutton LN; Elterman R; Lange B; Goldwein J; Nicholson HS; Mulne L; Boyett J; D'Angio G; Wechsler-Jentzsch K
J Neurosurg; 1994 Nov; 81(5):690-8. PubMed ID: 7931615
[TBL] [Abstract][Full Text] [Related]
7. Prognostic factors and treatment results for supratentorial primitive neuroectodermal tumors in children using radiation and chemotherapy: a Childrens Cancer Group randomized trial.
Cohen BH; Zeltzer PM; Boyett JM; Geyer JR; Allen JC; Finlay JL; McGuire-Cullen P; Milstein JM; Rorke LB; Stanley P
J Clin Oncol; 1995 Jul; 13(7):1687-96. PubMed ID: 7602359
[TBL] [Abstract][Full Text] [Related]
8. Randomized study for the treatment of adult advanced Hodgkin's disease: mechlorethamine, vincristine, procarbazine, and prednisone (MOPP) versus lomustine, vinblastine, and prednisone.
Liebman HA; Hum GJ; Sheehan WW; Ryden VM; Bateman JR
Cancer Treat Rep; 1983 May; 67(5):413-9. PubMed ID: 6342771
[TBL] [Abstract][Full Text] [Related]
9. Survival and prognostic factors following radiation and/or chemotherapy for primitive neuroectodermal tumors of the pineal region in infants and children: a report of the Childrens Cancer Group.
Jakacki RI; Zeltzer PM; Boyett JM; Albright AL; Allen JC; Geyer JR; Rorke LB; Stanley P; Stevens KR; Wisoff J
J Clin Oncol; 1995 Jun; 13(6):1377-83. PubMed ID: 7751882
[TBL] [Abstract][Full Text] [Related]
10. Results of the treatment of children with recurrent gliomas with lomustine and vincristine.
Lefkowitz IB; Packer RJ; Sutton LN; Siegel KR; Bruce DA; Evans AE; Schut L
Cancer; 1988 Mar; 61(5):896-902. PubMed ID: 3338054
[TBL] [Abstract][Full Text] [Related]
11. 5-Fluorouracil and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) followed by hydroxyurea, misonidazole, and irradiation for brain stem gliomas: a pilot study of the Brain Tumor Research Center and the Childrens Cancer Group.
Levin VA; Edwards MS; Wara WM; Allen J; Ortega J; Vestnys P
Neurosurgery; 1984 Jun; 14(6):679-81. PubMed ID: 6087193
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors in childhood ependymomas.
Sutton LN; Goldwein J; Perilongo G; Lang B; Schut L; Rorke L; Packer R
Pediatr Neurosurg; 1990-1991; 16(2):57-65. PubMed ID: 2132926
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of rubidomycin in induction therapy with vincristine, prednisone, and L-asparaginase for standard risk childhood acute lymphocytic leukemia: results of a Dutch phase III study (ALL V). A report on behalf of the Dutch Childhood Leukemia Study Group (DCLSG).
van der Does-van den Berg A; van Wering ER; Suciu S; Solbu G; van 't Veer MB; Rammeloo JA; de Koning J; van Zanen GE
Am J Pediatr Hematol Oncol; 1989; 11(2):125-33. PubMed ID: 2665546
[TBL] [Abstract][Full Text] [Related]
14. Pre-irradiation chemotherapy in children with high-grade astrocytoma: tumor response to two cycles of the '8-drugs-in-1-day' regimen. A Childrens Cancer Group study, CCG-945.
Finlay JL; Geyer JR; Turski PA; Yates AJ; Boyett JM; Allen JC; Packer RJ
J Neurooncol; 1994; 21(3):255-65. PubMed ID: 7699420
[TBL] [Abstract][Full Text] [Related]
15. ABVD versus modified stanford V versus MOPPEBVCAD with optional and limited radiotherapy in intermediate- and advanced-stage Hodgkin's lymphoma: final results of a multicenter randomized trial by the Intergruppo Italiano Linfomi.
Gobbi PG; Levis A; Chisesi T; Broglia C; Vitolo U; Stelitano C; Pavone V; Cavanna L; Santini G; Merli F; Liberati M; Baldini L; Deliliers GL; Angelucci E; Bordonaro R; Federico M;
J Clin Oncol; 2005 Dec; 23(36):9198-207. PubMed ID: 16172458
[TBL] [Abstract][Full Text] [Related]
16. Chemotherapy of primary brain tumors.
Levin VA
Neurol Clin; 1985 Nov; 3(4):855-66. PubMed ID: 3001491
[TBL] [Abstract][Full Text] [Related]
17. Phase III randomized study of postradiotherapy chemotherapy with alpha-difluoromethylornithine-procarbazine, N-(2-chloroethyl)-N'-cyclohexyl-N-nitrosurea, vincristine (DFMO-PCV) versus PCV for glioblastoma multiforme.
Levin VA; Uhm JH; Jaeckle KA; Choucair A; Flynn PJ; Yung WKA ; Prados MD; Bruner JM; Chang SM; Kyritsis AP; Gleason MJ; Hess KR
Clin Cancer Res; 2000 Oct; 6(10):3878-84. PubMed ID: 11051233
[TBL] [Abstract][Full Text] [Related]
18. Treatment of adult nonmetastatic medulloblastoma patients according to the paediatric HIT 2000 protocol: a prospective observational multicentre study.
Friedrich C; von Bueren AO; von Hoff K; Kwiecien R; Pietsch T; Warmuth-Metz M; Hau P; Deinlein F; Kuehl J; Kortmann RD; Rutkowski S
Eur J Cancer; 2013 Mar; 49(4):893-903. PubMed ID: 23182688
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant chemotherapy for medulloblastoma: the first multi-centre control trial of the International Society of Paediatric Oncology (SIOP I).
Tait DM; Thornton-Jones H; Bloom HJ; Lemerle J; Morris-Jones P
Eur J Cancer; 1990 Apr; 26(4):464-9. PubMed ID: 2141512
[TBL] [Abstract][Full Text] [Related]
20. Nitrogen mustard, vincristine, procarbazine, and prednisone as adjuvant chemotherapy in the treatment of medulloblastoma. A Pediatric Oncology Group study.
Krischer JP; Ragab AH; Kun L; Kim TH; Laurent JP; Boyett JM; Cornell CJ; Link M; Luthy AR; Camitta B
J Neurosurg; 1991 Jun; 74(6):905-9. PubMed ID: 2033450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
